What's breaking now, across thousands of outlets.
AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., in a megadeal that would create one of the world’s largest drugmakers, according to people familiar with the matter.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
The CLARITY Act's ethics deal routes enforcement through a DOJ run by Trump's former lawyer. A ban on issuing crypto that skips holding.
In his Sunday column, Jim Cramer explains why Amazon is his favorite hyperscaler after second-quarter earnings season.
Experts give tips on how to manage inflation, which is driven mainly by higher prices of food, cars, health insurance and petrol.
AI-native businesses need real-time finance, not monthly reports. Learn how predictive FP&A, telemetry, and AI cost governance are reshaping enterprise finance.
